Beta-blockers & TAVR study
Part of Heart & circulation clinical trials.
This study tests whether continuing a beta-blocker (a heart medication) improves outcomes for people having a planned TAVR (a minimally invasive heart-valve replacement). It may help doctors decide whether to keep or stop this medicine after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have a planned (not emergency) TAVR procedure, which is a minimally invasive heart-valve replacement.
- You have been taking a beta-blocker (a type of heart medication) for at least one month before the study starts.
- You must be able to understand what the study involves and give your permission (informed consent).
- You do not have a permanent pacemaker or need one right now.
- You haven't had a bad reaction to beta-blockers before.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This trial studies people who had a heart valve procedure called TAVI and later had a heart rhythm problem. You will get a tiny heart monitor placed under your skin to track your heart rhythm over time and help doctors understand how common these problems are.
This study tests whether stopping beta blockers after TAVI is safe and effective compared with continuing them. It may help clarify the best medication plan after valve replacement for people at higher surgical risk.
This study compares two treatments for severe aortic stenosis in people with a bicuspid aortic valve: transcatheter aortic valve replacement (TAVR, a less invasive procedure) and surgical aortic valve replacement (SAVR, open-heart surgery). The goal is to see which approach works better for this specific condition.
This study tests whether taking an angiotensin receptor blocker (a type of blood pressure pill) after TAVR helps the heart muscle recover in people with aortic stenosis and thickened heart walls. It's for patients who already had TAVR within the past month and meet safety criteria.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
Hear when a new Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.